Pharma in Focus
Email Address Sign-Up

Australia's most trusted source of pharma news

Buy now fake rolex

News

There is a link says EMA

Posted 8 April 2021 AM

AZ is working with European and UK regulators to update the label on its Covid vaccine following a finding by the EMA's safety committee (PRAC) that there is a link between the vax and a rare blood clotting disorder.

The EMA said overnight it had "concluded today that unusual blood clots with low blood platelets should be listed as very rare side effects of Vaxzevria (formerly COVID-19 Vaccine AstraZeneca)" but it continues to support the risk/benefit profile of the product.

Looks like you've lost your access to Pharma in Focus. To restore access or update your subscription, click here

Top of the Hill
All fine, nothing to see here
How politics made a mess of the rollout
Special Report
PBAC July Agenda
Committee to assess 36 submissions
Approvals Action
First copy of gout drug
Plus new formulations of PBS-listed drugs
Special Report
Aust Covid Vaccine Tracker
UPDATE: Distribution of two mRNA vaccines overseas